Comments from McGuff Compounding Pharmacy Services, Inc. to FDA Draft Guidance Re: 503A

Comment from McGuff Compounding Pharmacy Services, Inc.

• See attached file(s)

• Public Submission
• Posted:
  02/06/2014
• ID:
  FDA-2013-D-1444-0033